Search
for
Sort by
Research 331–360 of 1000+
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Gender-Affirming Hormone Therapy for Transgender Females
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- Effect of finasteride in idiopathic hirsutism
- Congenital adrenal hyperplasia
- Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Hormone therapy in acne
- Male hormonal contraception: looking back and moving forward
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Síndrome do nevo de Becker
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Antiandrogen Therapy for Skin and Hair Disease